Publications by Rumi Murata
15 publications found
Original articles
Clinical Evaluation of Onrad, A New Low-cost Version of TomoTherapy that Uses Only Static Beams
Kurume Med J, 65 (4), 129-136
DOI 10.2739/kurumemedj.MS654004, PubMed 31723077
Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience
Jpn J Radiol, 34 (4), 292-9
DOI 10.1007/s11604-016-0524-8, PubMed 26852128
Intensity modulated stereotactic body radiation therapy for single or multiple vertebral metastases with spinal cord compression
Pract Radiat Oncol, 4 (6), e231-7
DOI 10.1016/j.prro.2014.02.005, PubMed 25407874
Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical mode
Radiat Oncol, 8, 68
DOI 10.1186/1748-717X-8-68, PubMed 23517931
Radiotherapy for hilar or mediastinal lymph node metastases after definitive treatment with stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer
Pract Radiat Oncol, 2 (4), e137-e143
DOI 10.1016/j.prro.2011.11.007, PubMed 24674177
Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor
Int J Radiat Oncol Biol Phys, 81 (5), 1538-43
DOI 10.1016/j.ijrobp.2011.05.034, PubMed 22115556
Correlation between the serum KL-6 level and the grade of radiation pneumonitis after stereotactic body radiotherapy for stage I lung cancer or small lung metastasis
Radiother Oncol, 101 (2), 267-70
DOI 10.1016/j.radonc.2011.05.031, PubMed 21640420
Non-invasive imaging of combretastatin activity in two tumor models: Association with invasive estimates
Acta Oncol, 49 (7), 906-13
DOI 10.3109/0284186X.2010.499135, PubMed 20831477
Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
Radiat Oncol, 5, 81
DOI 10.1186/1748-717X-5-81, PubMed 20849623
Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study
Int J Radiat Oncol Biol Phys, 75 (2), 482-8
DOI 10.1016/j.ijrobp.2008.12.093, PubMed 19735872
Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole
Radiother Oncol, 87 (3), 331-8
DOI 10.1016/j.radonc.2008.03.002, PubMed 18375007
Preclinical studies to predict efficacy of vascular changes induced by combretastatin a-4 disodium phosphate in patients
Int J Radiat Oncol Biol Phys, 70 (3), 859-66
DOI 10.1016/j.ijrobp.2007.10.012, PubMed 18164835
Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma
Eur J Nucl Med Mol Imaging, 31 (4), 513-20
DOI 10.1007/s00259-003-1404-x, PubMed 14722675
Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response
Int J Radiat Oncol Biol Phys, 57 (4), 1047-55
DOI 10.1016/s0360-3016(03)00769-7, PubMed 14575836
Combination of vascular targeting agents with thermal or radiation therapy
Int J Radiat Oncol Biol Phys, 54 (5), 1518-23
DOI 10.1016/s0360-3016(02)03926-3, PubMed 12459380